Argen-x
argen-x.com
Next generation therapeutic antibody

arGEN-X develops the SIMPLE Antibody platform: a limitless source of extremely high quality human antibodies which modulate the function of any disease target, including complex receptors and highly conserved targets. Unprecedented choice of antibody leads with intrinsic drug qualities dramatically increases the efficiency of antibody discovery and success in development.

News :


Argen-x Raises € 27.5 Million...
12/01/2011

Argen-x Raises € 27.5 Million (USD 37 Million) In Oversubscribed Series B Round
Read more
PDF File